Inventor

LANZAVECCHIA ANTONIO

CH66 patents

⚠️ This page may combine multiple inventors who share the name “LANZAVECCHIA ANTONIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LANZAVECCHIA ANTONIO

LANZAVECCHIA ANTONIO

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Neutralizing anti-influenza A virus antibodies and uses thereof

Human cytomegalovirus neutralising antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralising antibodies and use thereof

Human cytomegalovirus neutralising antibodies and use thereof

Neutralizing anti-influenza A virus antibodies and uses thereof

Neutralizing anti-influenza A virus antibodies and uses thereof

Neutralizing anti-influenza A virus antibodies and uses thereof

Antibodies against H5N1 strains of influenza A virus

Monoclonal antibody production by EBV transformation of B cells

INST RESEARCH IN BIOMEDICINE

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralising antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Monoclonal antibody production by EBV transformation of B cells

INST FOR RES IN BIOMEDICINE

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralising antibodies and use thereof

US HEALTH

Recombinant metapneumovirus F proteins and their use

Prefusion PIV F immunogens and their use

Prefusion PIV F immunogens and their use

Recombinant metapneumovirus f proteins and their use

Prefusion PIV F immunogens and their use

Recombinant metapneumovirus F proteins and their use

Recombinant metapneumovirus F proteins and their use

MEDIMMUNE LLC

Neutralizing anti-influenza B antibodies and uses thereof

Neutralizing anti-influenza B antibodies and uses thereof

Neutralizing anti-influenza B antibodies and uses thereof

Neutralizing anti-influenza A antibodies and uses thereof

Neutralizing anti-influenza b antibodies and uses thereof

Neutralizing anti-influenza B antibodies and uses thereof

INST RES BIOMEDICINE

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Neutralizing anti-influenza A virus antibodies and uses thereof

Human cytomegalovirus neutralizing antibodies and use thereof

HUMABS LLC

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralising antibodies and use thereof

MICROMET AG

Potent T cell modulating molecules

UNIV WASHINGTON

Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their use